CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-05 | CHILDS JOHN W Director | Purchase | +318,000 | $22.00 | $7.0M | 3,998,952 |
| 2023-10-05 | CHILDS JOHN W Director | Purchase | +136,545 | $22.00 | $3.0M | 2,111,663 |
| 2023-10-05 | Coric Vlad Chief Executive Officer | Purchase | +340,908 | $22.00 | $7.5M | 833,120 |
| 2023-10-05 | Coric Vlad Chief Executive Officer | Purchase | +113,637 | $22.00 | $2.5M | 1,657,031 |
| 2023-10-05 | Buten Matthew Chief Financial Officer | Purchase | +22,727 | $22.00 | $500K | 189,380 |
| 2023-10-04 | Bailey Gregory Director | Purchase | +17,817 | $22.57 | $402K | 1,525,788 |
| 2023-08-30 | CHILDS JOHN W Director | Purchase | +50,000 | $18.44 | $922K | 1,975,118 |
| 2023-08-04 | CHILDS JOHN W Director | Purchase | +100,000 | $19.78 | $2.0M | 1,925,118 |
| 2023-05-02 | Bailey Gregory Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | Mehta Kishan Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | GREGORY JULIA P Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | Antonijevic Irina Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | CHILDS JOHN W Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2023-05-02 | HUGIN ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +52,906 | 52,906 | ||
| 2022-10-31 | Coric Vlad Chief Executive Officer | Purchase | +25,800 | $15.97 | $412K | 1,543,394 |
| 2022-10-28 | Coric Vlad Chief Executive Officer | Purchase | +41,930 | $14.87 | $623K | 1,517,594 |
| 2022-10-28 | Coric Vlad Chief Executive Officer | Purchase | +100,000 | $14.82 | $1.5M | 109,565 |
| 2022-10-25 | CHILDS JOHN W Director | Purchase | +2,380,952 | $10.50 | $25.0M | 3,680,952 |
| 2022-10-25 | CHILDS JOHN W Director | Purchase | +1,328,867 | $10.50 | $14.0M | 1,825,118 |
Page 7 of 18 · 355 trades